Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
Sustol
granisetron
- Formulary Serotonin Receptor Antagonists (5-HT3)Formulary
- Non-formulary
- Therapeutic Interchange
VIEW MORE 5-HT3 Receptor Antagonists
Last updated: Dec. 26, 2017
Ordered Formulation
Therapeutic Interchange
granisetron (Sustol)
10 mg extended release subQ on day 1 of chemotherapy, then once every 7 days
ondansetron (Zofran)
16 mg IV or PO
Sustol injection medication guide
Sustol is non-formulary. Interchange to ondansetron oral tablets or intravenous injection. 16 mg dose x 1 dose at each dose of chemotherapy. Reviewed by Oncology subcommittee.
Sancuso Patch is non-formulary, not stocked. If ordered for an inpatient, contact the physician and have changed to a formulary agent. If a patient is admitted with a patch that had been applied as an outpatient, the patch should be discontinued and the physician should be notified.
Reviewed: December 16, 2009 (Sancuso Patch) and 28 Feb 2017 (Sustol)